Video
- Author:
- Sara Freeman
Publish date: June 16, 2017
MADRID – Tropinin T levels may help assess cardiovascular risk in patients with lupus.
News
- Author:
- Sara Freeman
Publish date: June 15, 2017
Prophylaxis for steroid-associated pneumonia is a winner in patients with rheumatic diseases.
News
- Author:
- Sara Freeman
Publish date: May 16, 2017
Calculation of neutrophil to leukocyte ratio could save some patients from steroid therapy.
News
- Author:
- Sara Freeman
Publish date: May 15, 2017
BIRMINGHAM, ENGLAND – A proportion of patients with ankylosing spondylitis (AS) were able to remain on a reduced-dose regimen of a tumor necrosis f...
News
- Author:
- Sara Freeman
Publish date: May 15, 2017
BIRMINGHAM, ENGLAND – Reducing levels of joint pain and inflammation did not appreciably improve mental well-being.
News
- Author:
- Sara Freeman
Publish date: May 15, 2017
There are currently five ongoing multicenter phase III trials being undertaken with four drugs.
News
- Author:
- Sara Freeman
Publish date: May 15, 2017
BIRMINGHAM, ENGLAND – Smartphone apps in development for patients with rheumatoid arthritis are designed to monitor the activity of both the patien...
News
- Author:
- Sara Freeman
Publish date: May 12, 2017
BIRMINGHAM, ENGLAND – Smoking at any level appears to worsen disease activity.
News
- Author:
- Sara Freeman
Publish date: May 9, 2017
BIRMINGHAM, ENGLAND – New criteria for classifying granulomatosis with polyangiitis have been proposed by the ACR and EULAR.
News
- Author:
- Sara Freeman
Publish date: May 8, 2017
BIRMINGHAM, ENGLAND – Patients being treated with biologics for rheumatoid arthritis have a low risk for developing opportunistic infections, based...
News
- Author:
- Sara Freeman
Publish date: May 1, 2017
AMSTERDAM – Selective internal radiotherapy was found to be better tolerated than standard therapy but did not meet the primary endpoint of improve...
Article
- Author:
- Sara Freeman
Publish date: May 1, 2017
AMSTERDAM – The treatment was safe and multiple biochemical measurements showed significant improvement.
News
- Author:
- Sara Freeman
Publish date: April 28, 2017
Infections at 6 and 12 months were secondary outcomes of a norfloxacin study and showed fewer infections overall.
News
- Author:
- Sara Freeman
Publish date: April 28, 2017
BIRMINGHAM, ENGLAND – There are also “extremely large differences” on patient-reported measures between patients meeting criteria for both conditio...
News
- Author:
- Sara Freeman
Publish date: April 28, 2017
BIRMINGHAM, ENGLAND – Inhibition of RA radiographic progression seen at the end of the MOBILITY trial in both the 150-mg and 200-mg active treatmen...
